These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29064732)

  • 81. AAV Infection: Protection from Cancer.
    Srivastava A; Carter BJ
    Hum Gene Ther; 2017 Apr; 28(4):323-327. PubMed ID: 27832705
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of naturally-occurring humoral immunity to AAV in sheep.
    Tellez J; Van Vliet K; Tseng YS; Finn JD; Tschernia N; Almeida-Porada G; Arruda VR; Agbandje-McKenna M; Porada CD
    PLoS One; 2013; 8(9):e75142. PubMed ID: 24086458
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy.
    Chen Y; Zheng S; Tecedor L; Davidson BL
    Mol Ther; 2018 Apr; 26(4):1118-1126. PubMed ID: 29503202
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1.
    Kitajima K; Marchadier DH; Burstein H; Rader DJ
    Atherosclerosis; 2006 May; 186(1):65-73. PubMed ID: 16099465
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors.
    Liu Q; Huang W; Zhang H; Wang Y; Zhao J; Song A; Xie H; Zhao C; Gao D; Wang Y
    Gene Ther; 2014 Aug; 21(8):732-8. PubMed ID: 24849042
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cell-Based Determination of Neutralizing Antibodies Against Adeno-Associated Virus in Cardiac Gene Therapy.
    Ravichandran AJ; Mazurek R; Ishikawa K
    Methods Mol Biol; 2022; 2573():293-304. PubMed ID: 36040603
    [TBL] [Abstract][Full Text] [Related]  

  • 87. OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
    Mietzsch M; Hering H; Hammer EM; Agbandje-McKenna M; Zolotukhin S; Heilbronn R
    Hum Gene Ther Methods; 2017 Feb; 28(1):15-22. PubMed ID: 28125901
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.
    Sen S; Conroy S; Hynes SO; McMahon J; O'Doherty A; Bartlett JS; Akhtar Y; Adegbola T; Connolly CE; Sultan S; Barry F; Katusic ZS; O'Brien T
    J Gene Med; 2008 Feb; 10(2):143-51. PubMed ID: 18067196
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
    Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
    J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency.
    Hacker UT; Wingenfeld L; Kofler DM; Schuhmann NK; Lutz S; Herold T; King SB; Gerner FM; Perabo L; Rabinowitz J; McCarty DM; Samulski RJ; Hallek M; Büning H
    J Gene Med; 2005 Nov; 7(11):1429-38. PubMed ID: 15945124
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors.
    Blits B; Derks S; Twisk J; Ehlert E; Prins J; Verhaagen J
    J Neurosci Methods; 2010 Jan; 185(2):257-63. PubMed ID: 19850079
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes.
    Wu Z; Asokan A; Grieger JC; Govindasamy L; Agbandje-McKenna M; Samulski RJ
    J Virol; 2006 Nov; 80(22):11393-7. PubMed ID: 16943302
    [TBL] [Abstract][Full Text] [Related]  

  • 93. High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes.
    Gardner MR; Mendes DE; Muniz CP; Martinez-Navio JM; Fuchs SP; Gao G; Desrosiers RC
    Mol Ther Methods Clin Dev; 2022 Mar; 24():199-206. PubMed ID: 35141348
    [TBL] [Abstract][Full Text] [Related]  

  • 94. High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.
    Hüser D; Khalid D; Lutter T; Hammer EM; Weger S; Heßler M; Kalus U; Tauchmann Y; Hensel-Wiegel K; Lassner D; Heilbronn R
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928011
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Development of AAV serotype-specific ELISAs using novel monoclonal antibodies.
    Kuck D; Kern A; Kleinschmidt JA
    J Virol Methods; 2007 Mar; 140(1-2):17-24. PubMed ID: 17126418
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
    Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
    Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
    [TBL] [Abstract][Full Text] [Related]  

  • 97. AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid.
    Su H; Yeghiazarians Y; Lee A; Huang Y; Arakawa-Hoyt J; Ye J; Orcino G; Grossman W; Kan YW
    J Gene Med; 2008 Jan; 10(1):33-41. PubMed ID: 18044793
    [TBL] [Abstract][Full Text] [Related]  

  • 98. SGSH gene transfer in mucopolysaccharidosis type IIIA mice using canine adenovirus vectors.
    Lau AA; Hopwood JJ; Kremer EJ; Hemsley KM
    Mol Genet Metab; 2010 Jun; 100(2):168-75. PubMed ID: 20231109
    [TBL] [Abstract][Full Text] [Related]  

  • 99. AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses.
    Mendoza SD; El-Shamayleh Y; Horwitz GD
    J Neurophysiol; 2017 May; 117(5):2004-2013. PubMed ID: 28202570
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reduced Immunogenicity of Intraparenchymal Delivery of Adeno-Associated Virus Serotype 2 Vectors: Brief Overview.
    Hwu WL; Muramatsu SI; Gidoni-Ben-Zeev B
    Curr Gene Ther; 2022; 22(3):185-190. PubMed ID: 34551695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.